Xiangyu Medical Co Ltd
SSE:688626

Watchlist Manager
Xiangyu Medical Co Ltd Logo
Xiangyu Medical Co Ltd
SSE:688626
Watchlist
Price: 29.7 CNY -4.65% Market Closed
Market Cap: 4.8B CNY
Have any thoughts about
Xiangyu Medical Co Ltd?
Write Note

Xiangyu Medical Co Ltd
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Xiangyu Medical Co Ltd
Total Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Xiangyu Medical Co Ltd
SSE:688626
Total Equity
ÂĄ2.1B
CAGR 3-Years
41%
CAGR 5-Years
38%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Total Equity
ÂĄ1.9B
CAGR 3-Years
61%
CAGR 5-Years
48%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Total Equity
ÂĄ12.1B
CAGR 3-Years
14%
CAGR 5-Years
15%
CAGR 10-Years
22%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Total Equity
ÂĄ38.8B
CAGR 3-Years
17%
CAGR 5-Years
19%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Total Equity
ÂĄ3B
CAGR 3-Years
-2%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Total Equity
ÂĄ18.9B
CAGR 3-Years
74%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Xiangyu Medical Co Ltd
Glance View

Market Cap
4.7B CNY
Industry
Health Care

Xiangyu Medical Co., Ltd. engages in the development, procurement, production, and sale of rehabilitation medical equipment. The company is headquartered in Anyang, Henan and currently employs 1,727 full-time employees. The company went IPO on 2021-03-31. The firm is mainly engaged in the independent research and development, production and marketing of intelligent rehabilitation equipment in the rehabilitation fields such as pain, neurology, orthopedics, traditional Chinese medicine, postpartum field, postoperative field, cardiopulmonary field, and medical-care integration. The firm's main products are divided into three categories: rehabilitation assessment, rehabilitation training, and rehabilitation physiotherapy. The firm mainly conducts business within the domestic market.

Intrinsic Value
47.32 CNY
Undervaluation 37%
Intrinsic Value
Price

See Also

What is Xiangyu Medical Co Ltd's Total Equity?
Total Equity
2.1B CNY

Based on the financial report for Dec 31, 2023, Xiangyu Medical Co Ltd's Total Equity amounts to 2.1B CNY.

What is Xiangyu Medical Co Ltd's Total Equity growth rate?
Total Equity CAGR 5Y
38%

Over the last year, the Total Equity growth was 8%. The average annual Total Equity growth rates for Xiangyu Medical Co Ltd have been 41% over the past three years , 38% over the past five years .

Back to Top